A pilot phase II study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.Lauren Cobb, Amir A. Jazaeri, David M. Gershenson et al.|Journal of Clinical Oncology|2022Cited by 34